首页 > 最新文献

Revista clinica espanola最新文献

英文 中文
The effect of age on the accuracy of light's criteria. 年龄对光标准准确性的影响。
Pub Date : 2026-02-06 DOI: 10.1016/j.rceng.2026.502486
Wen-Qi Zheng, Silvia Bielsa, Yan Niu, Jian-Xun Wen, Li Yan, Zhi-De Hu, José M Porcel

Objective: This study aimed to investigate the effects of age on the sensitivity, specificity, and accuracy of Light's criteria to differentiate exudative from transudative pleural effusion.

Methods: A testing cohort from China and a validation cohort from Spain were used for data analysis. The testing cohort included 302 patients (59 transudates and 243 exudates) with undiagnosed pleural effusion. The validation cohort comprised 400 patients (200 transudates and 200 exudates) divided into two groups according to age (200 patients aged 50-65 years and 200 patients aged 80-95 years). The effects of age on the sensitivity, specificity, and accuracy of Light's criteria were determined by sampling patients with different age limits.

Results: In the testing cohort, the sensitivity and specificity of Light's criteria for exudate were 0.91 and 0.73, respectively. In the validation cohort, the sensitivity was 0.99 and 0.97, and the specificity of Light's criteria for exudate was 0.73 and 0.68, respectively, by age group. The diagnostic accuracy metrics (sensitivity, specificity, and accuracy) of Light's criteria and its items tended to decrease with age.

Conclusion: Age should be considered when interpreting the Light's criteria.

目的:探讨年龄对Light鉴别渗出性胸腔积液和透出性胸腔积液的敏感性、特异性和准确性的影响。方法:采用来自中国的检验队列和来自西班牙的验证队列进行数据分析。试验队列包括302例未确诊的胸腔积液患者(59例渗出患者和243例渗出患者)。验证队列包括400例患者(200例转体和200例渗出),按年龄分为两组(200例50-65岁和200例80-95岁)。年龄对Light标准的敏感性、特异性和准确性的影响是通过抽样不同年龄限制的患者来确定的。结果:在检测队列中,Light’s标准对渗出液的敏感性为0.91,特异性为0.73。在验证队列中,按年龄组划分,Light标准的敏感性分别为0.99和0.97,特异性分别为0.73和0.68。Light标准及其项目的诊断准确性指标(敏感性、特异性和准确性)随着年龄的增长而下降。结论:在解释光的标准时应考虑年龄。
{"title":"The effect of age on the accuracy of light's criteria.","authors":"Wen-Qi Zheng, Silvia Bielsa, Yan Niu, Jian-Xun Wen, Li Yan, Zhi-De Hu, José M Porcel","doi":"10.1016/j.rceng.2026.502486","DOIUrl":"https://doi.org/10.1016/j.rceng.2026.502486","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to investigate the effects of age on the sensitivity, specificity, and accuracy of Light's criteria to differentiate exudative from transudative pleural effusion.</p><p><strong>Methods: </strong>A testing cohort from China and a validation cohort from Spain were used for data analysis. The testing cohort included 302 patients (59 transudates and 243 exudates) with undiagnosed pleural effusion. The validation cohort comprised 400 patients (200 transudates and 200 exudates) divided into two groups according to age (200 patients aged 50-65 years and 200 patients aged 80-95 years). The effects of age on the sensitivity, specificity, and accuracy of Light's criteria were determined by sampling patients with different age limits.</p><p><strong>Results: </strong>In the testing cohort, the sensitivity and specificity of Light's criteria for exudate were 0.91 and 0.73, respectively. In the validation cohort, the sensitivity was 0.99 and 0.97, and the specificity of Light's criteria for exudate was 0.73 and 0.68, respectively, by age group. The diagnostic accuracy metrics (sensitivity, specificity, and accuracy) of Light's criteria and its items tended to decrease with age.</p><p><strong>Conclusion: </strong>Age should be considered when interpreting the Light's criteria.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502486"},"PeriodicalIF":0.0,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146145079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to: GRADE methodology in consensus and clinical practice guidelines for the management of retinal vein occlusion. 对视网膜静脉闭塞治疗的共识和临床实践指南中的GRADE方法的回应。
Pub Date : 2026-02-06 DOI: 10.1016/j.rceng.2026.502482
Javier Pagán Escribano
{"title":"Response to: GRADE methodology in consensus and clinical practice guidelines for the management of retinal vein occlusion.","authors":"Javier Pagán Escribano","doi":"10.1016/j.rceng.2026.502482","DOIUrl":"https://doi.org/10.1016/j.rceng.2026.502482","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502482"},"PeriodicalIF":0.0,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146145519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Start of sodium-glucose cotransporter type 2 inhibitors (iSGLT2) in patients with acute heart failure in the Emergency room? 急症室急性心力衰竭患者开始使用钠-葡萄糖共转运蛋白2型抑制剂(iSGLT2) ?
Pub Date : 2026-02-06 DOI: 10.1016/j.rceng.2026.502470
P Herrero-Puente, Á González Franco
{"title":"Start of sodium-glucose cotransporter type 2 inhibitors (iSGLT2) in patients with acute heart failure in the Emergency room?","authors":"P Herrero-Puente, Á González Franco","doi":"10.1016/j.rceng.2026.502470","DOIUrl":"https://doi.org/10.1016/j.rceng.2026.502470","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502470"},"PeriodicalIF":0.0,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146145480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evolution of radiologic alterations in patients unvaccinated with covid-19 pneumonia and prediction of lung fibrosis development at 6 months according to predictive model. 基于预测模型的未接种covid-19肺炎患者放射学改变演变及6个月肺纤维化发展预测
Pub Date : 2026-02-06 DOI: 10.1016/j.rceng.2026.502488
Selene Cuenca Peris, Margarita Marín Royo, Santiago F Marco Domenech

Introduction: Alteration in pulmonary function tests and radiological abnormalities are present in a significant percentage of COVID-19 survivors. Our aim is to evaluate radiological findings and functional respiratory parameters involved in lung fibrosis at six months after SARS-CoV-2 pneumonia and use initial score of the predictive model to predict fibrotic-like changes at 6 months.

Material and methods: Prospective observational study including unvaccinated patients with COVID-19 pneumonia. Pulmonary function tests and chest CT were performed six months after acute pneumonia.

Results: 109 patients were included. Bilateral ground-glass opacities (94%) were the most frequent radiological finding, followed by bilateral consolidations (36%) and crazy paving patterns (28%). Ct tracking shows a significant decrease in bilateral ground glass, consolidations and bilateral crazy paving at 6 months. In contrast, architectural distortion tends to increase over time. The presence of bronchial dilatation, subpleural curved line and parenchymal bands on initial CT were associated with radiological signs of lung fibrosis at 6 months. An initial score of the predictive model > 0.6 predicts fibrotic-like changes at 6 months (AUC 77.8%; Specificity 85.4%; Sensitivity 58.1%). The proportion of patients with DLCO < 80% was 55%.

Conclusions: In 50 patients, 6 months CT detected signs of fibrotic-like changes. The presence of bronchial dilatation, subpleural curved line and parenchymal bands could be used as early predictors of fibrotic-like changes in patients with COVID-19 pneumonia. Initial score of the predictive model> 0,6 allows the selection of patients at risk of developing pulmonary fibrotic-like changes. DLCO was the one most frequently impaired at 6 months.

在很大比例的COVID-19幸存者中存在肺功能检查改变和影像学异常。我们的目的是评估SARS-CoV-2肺炎后6个月与肺纤维化相关的影像学表现和功能呼吸参数,并使用预测模型的初始评分来预测6个月时的纤维化样变化。材料和方法:前瞻性观察研究,纳入未接种疫苗的COVID-19肺炎患者。急性肺炎后6个月进行肺功能检查和胸部CT检查。结果:纳入109例患者。双侧磨玻璃混浊(94%)是最常见的影像学表现,其次是双侧实变(36%)和疯狂铺路模式(28%)。Ct跟踪显示,6个月时双侧磨玻璃、固结、双侧狂铺明显减少。相反,随着时间的推移,体系结构的扭曲倾向于增加。最初CT上支气管扩张、胸膜下弯曲线和实质带的出现与6个月时肺纤维化的影像学征象有关。预测模型初始评分> 0.6预测6个月时的纤维样改变(AUC 77.8%,特异性85.4%,敏感性58.1%)。结论:在50例患者中,6个月CT检测到纤维样改变征象。支气管扩张、胸膜下曲线和实质带的存在可作为COVID-19肺炎患者纤维化样改变的早期预测指标。预测模型> 0,6的初始评分允许选择有发生肺纤维化样改变风险的患者。DLCO在6个月时最常受损。
{"title":"Evolution of radiologic alterations in patients unvaccinated with covid-19 pneumonia and prediction of lung fibrosis development at 6 months according to predictive model.","authors":"Selene Cuenca Peris, Margarita Marín Royo, Santiago F Marco Domenech","doi":"10.1016/j.rceng.2026.502488","DOIUrl":"https://doi.org/10.1016/j.rceng.2026.502488","url":null,"abstract":"<p><strong>Introduction: </strong>Alteration in pulmonary function tests and radiological abnormalities are present in a significant percentage of COVID-19 survivors. Our aim is to evaluate radiological findings and functional respiratory parameters involved in lung fibrosis at six months after SARS-CoV-2 pneumonia and use initial score of the predictive model to predict fibrotic-like changes at 6 months.</p><p><strong>Material and methods: </strong>Prospective observational study including unvaccinated patients with COVID-19 pneumonia. Pulmonary function tests and chest CT were performed six months after acute pneumonia.</p><p><strong>Results: </strong>109 patients were included. Bilateral ground-glass opacities (94%) were the most frequent radiological finding, followed by bilateral consolidations (36%) and crazy paving patterns (28%). Ct tracking shows a significant decrease in bilateral ground glass, consolidations and bilateral crazy paving at 6 months. In contrast, architectural distortion tends to increase over time. The presence of bronchial dilatation, subpleural curved line and parenchymal bands on initial CT were associated with radiological signs of lung fibrosis at 6 months. An initial score of the predictive model > 0.6 predicts fibrotic-like changes at 6 months (AUC 77.8%; Specificity 85.4%; Sensitivity 58.1%). The proportion of patients with DLCO < 80% was 55%.</p><p><strong>Conclusions: </strong>In 50 patients, 6 months CT detected signs of fibrotic-like changes. The presence of bronchial dilatation, subpleural curved line and parenchymal bands could be used as early predictors of fibrotic-like changes in patients with COVID-19 pneumonia. Initial score of the predictive model> 0,6 allows the selection of patients at risk of developing pulmonary fibrotic-like changes. DLCO was the one most frequently impaired at 6 months.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502488"},"PeriodicalIF":0.0,"publicationDate":"2026-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146145548","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GRADE methodology in consensus and clinical practice guidelines for the management of retinal vein occlusion. GRADE方法在视网膜静脉闭塞治疗的共识和临床实践指南。
Pub Date : 2026-02-02 DOI: 10.1016/j.rceng.2026.502469
C Burgueño-Montañes, R Bouchikh-El Jarroudi, M Zavaleta-Mercado, J Galvez-Olortegui
{"title":"GRADE methodology in consensus and clinical practice guidelines for the management of retinal vein occlusion.","authors":"C Burgueño-Montañes, R Bouchikh-El Jarroudi, M Zavaleta-Mercado, J Galvez-Olortegui","doi":"10.1016/j.rceng.2026.502469","DOIUrl":"10.1016/j.rceng.2026.502469","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502469"},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Emergency room visits by older patients living with HIV: an approach based on the EDEN registry. 老年艾滋病毒感染者急诊室就诊:一种基于EDEN登记的方法
Pub Date : 2026-02-02 DOI: 10.1016/j.rceng.2026.502474
Ò Miró, L Sentís, M Carbó, E Miró, D Mérida, J G Del Castillo

Objective: To investigate the incidence, sociodemographic characteristics, baseline status and evolution of elderly people living with HIV infection (PLHIV) attended in Spanish hospital emergency departments (ED).

Methods: Patients included in the EDEN (Emergency Department and Elder Needs) registry, which includes all patients aged 65 or older attended in 52 Spanish EDs during 7 consecutive days in 2019, were analyzed. Two groups were constructed according to whether or not they had known HIV infection (PLHIV and non-LHIV). We collected 6 sociodemographic factors and 8 referring to the patient's baseline situation. We recorded whether the episode of ED care required hospitalization, intensive care unit (ICU) admission, prolonged ED and inpatient stay, and in-hospital mortality, as well as reconsultation to the ED, rehospitalization, and death from any cause during the 3 years after discharge. The sociodemographic and baseline characteristics and the evolution of patients in the PLHIV and non-PLHIV groups were compared.

Results: Of 25,557 patients in the EDEN registry, 78 were PLHIV (0.30%, 95% CI 0.24% to 0.38%). The annual ED frequentation rate of PLHIV and non-PVHIV was 811 and 573 per 1000 population, respectively. The sociodemographic and baseline conditions were similar between PLHIV and non-PLHIV, with only age differing (younger PLHIV). Older PLHIV had severe comorbidity (27%), some type of functional limitation (27%) and cognitive impairment (11%). The most frequent ED diagnoses in PLHIV were pneumonia or lower respiratory tract infection (11%), heart failure or cardiogenic shock (8%) and joint and axial pain (6%), and in the non-HIV group there were no new diagnoses of HIV infection. 24.4% of PLHIV were hospitalized, 27.3% had a prolonged stay in the ED, 50% had prolonged hospitalization, 7.7% had in-hospital mortality, and reconsultation to the ED, hospitalization, and death during the 3 years post-discharge were 67%, 45.6%, and 21.7%, respectively. No outcome differed between PLHIV and non-PLHIV.

Conclusions: Older PLHIV have sociodemographic and baseline characteristics like the general population, but their rate of ED visits is higher. The severity of the episodes leading to this ED consultation is similar between PLHIV and non-PLHIV and long-term follow-up also shows no differences.

目的:了解西班牙医院急诊科(ED)老年人HIV感染(PLHIV)的发生率、社会人口学特征、基线状况及其演变。方法:对EDEN(急诊科和老年人需求)登记处的患者进行分析,该登记处包括2019年连续7天在52个西班牙急诊科就诊的所有65岁及以上患者。根据是否已知HIV感染分为PLHIV和non-LHIV两组。我们收集了6个社会人口学因素和8个涉及患者基线情况的因素。我们记录了在出院后的3年内,急诊科的发作是否需要住院、重症监护病房(ICU)入院、延长急诊科和住院时间、住院死亡率、再咨询急诊科、再住院和任何原因死亡。比较PLHIV组和非PLHIV组患者的社会人口学特征和基线特征及其演变。结果:在EDEN登记的25557例患者中,78例为PLHIV (0.30%, 95% CI 0.24%至0.38%)。PLHIV和非pvhiv的ED年发病率分别为811 / 1000和573 / 1000。PLHIV和非PLHIV之间的社会人口学和基线条件相似,只是年龄不同(年轻的PLHIV)。老年PLHIV患者有严重的合并症(27%),某种类型的功能限制(27%)和认知障碍(11%)。PLHIV患者中最常见的ED诊断为肺炎或下呼吸道感染(11%)、心力衰竭或心源性休克(8%)、关节和轴性疼痛(6%),而非HIV组中没有新的HIV感染诊断。24.4%的PLHIV患者住院,27.3%的患者在急诊科长时间住院,50%的患者长时间住院,7.7%的患者住院死亡,出院后3年内再诊、住院和死亡的比例分别为67%、45.6%和21.7%。PLHIV和非PLHIV之间没有结果差异。结论:老年hiv患者具有与普通人群相似的社会人口学特征和基线特征,但其急诊科就诊率较高。在PLHIV和非PLHIV患者中,导致ED会诊的发作的严重程度相似,长期随访也没有差异。
{"title":"Emergency room visits by older patients living with HIV: an approach based on the EDEN registry.","authors":"Ò Miró, L Sentís, M Carbó, E Miró, D Mérida, J G Del Castillo","doi":"10.1016/j.rceng.2026.502474","DOIUrl":"10.1016/j.rceng.2026.502474","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the incidence, sociodemographic characteristics, baseline status and evolution of elderly people living with HIV infection (PLHIV) attended in Spanish hospital emergency departments (ED).</p><p><strong>Methods: </strong>Patients included in the EDEN (Emergency Department and Elder Needs) registry, which includes all patients aged 65 or older attended in 52 Spanish EDs during 7 consecutive days in 2019, were analyzed. Two groups were constructed according to whether or not they had known HIV infection (PLHIV and non-LHIV). We collected 6 sociodemographic factors and 8 referring to the patient's baseline situation. We recorded whether the episode of ED care required hospitalization, intensive care unit (ICU) admission, prolonged ED and inpatient stay, and in-hospital mortality, as well as reconsultation to the ED, rehospitalization, and death from any cause during the 3 years after discharge. The sociodemographic and baseline characteristics and the evolution of patients in the PLHIV and non-PLHIV groups were compared.</p><p><strong>Results: </strong>Of 25,557 patients in the EDEN registry, 78 were PLHIV (0.30%, 95% CI 0.24% to 0.38%). The annual ED frequentation rate of PLHIV and non-PVHIV was 811 and 573 per 1000 population, respectively. The sociodemographic and baseline conditions were similar between PLHIV and non-PLHIV, with only age differing (younger PLHIV). Older PLHIV had severe comorbidity (27%), some type of functional limitation (27%) and cognitive impairment (11%). The most frequent ED diagnoses in PLHIV were pneumonia or lower respiratory tract infection (11%), heart failure or cardiogenic shock (8%) and joint and axial pain (6%), and in the non-HIV group there were no new diagnoses of HIV infection. 24.4% of PLHIV were hospitalized, 27.3% had a prolonged stay in the ED, 50% had prolonged hospitalization, 7.7% had in-hospital mortality, and reconsultation to the ED, hospitalization, and death during the 3 years post-discharge were 67%, 45.6%, and 21.7%, respectively. No outcome differed between PLHIV and non-PLHIV.</p><p><strong>Conclusions: </strong>Older PLHIV have sociodemographic and baseline characteristics like the general population, but their rate of ED visits is higher. The severity of the episodes leading to this ED consultation is similar between PLHIV and non-PLHIV and long-term follow-up also shows no differences.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502474"},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current situation and role of internists in healthcare ethics committees in Spain. PANACEAS study. 西班牙内科医生在医疗伦理委员会中的现状和作用。灵丹妙药。
Pub Date : 2026-02-02 DOI: 10.1016/j.rceng.2026.502483
P Durán Del Campo, G Solano Iturri, B Alonso Ortiz, J Bertran Muñoz, A M Bravo Blanco, L Briongos Figuero, C Carrera García, A D Chacón Moreno, A Blanco Portillo, J M Galván-Román

Objectives: To analyze the current situation of Healthcare Ethics Committees (HECs) in Spain, their composition and functions, as well as the implementation of Clinical Ethics Consultancy (CEC). Finally, to assess the involvement of internists in HECs.

Materials and methods: A cross-sectional descriptive study conducted through a self-administered online survey distributed between February and May 2025 to all identified HECs in the country.

Results: A total of 112 HECs (47.66%) out of the 235 accredited nationwide participated. The average number of members per committee was 16 (range: 6-29). The most represented professional profiles were nursing and medicine. In 99.1% of the committees, at least one member had postgraduate training in Bioethics. The most frequent range of meetings per year was between 7 and 12 (46.8%). Most HECs (91.1%) were involved in educational activities, and 58% had produced ethical documents. The majority reviewed between 1 and 5 cases annually (69.6%). The CEC role was established in 40.2% of HECs and in the process of implementation in 18.8%. Internists were present in 54% of HECs. In 65% of cases, the internist is part of the CEC.

Conclusions: HECs in Spain demonstrate significant involvement in educational activities and the development of ethical documents; however, they receive a relatively low number of annual consultations. Clinical Ethics Consultancy is gradually being integrated into the structure of HECs, which may enhance the management of ethical inquiries. Internists are members of more than half of the HECs and play a very active role in their operations.

目的:分析西班牙医疗伦理委员会(HECs)的现状、组成和职能,以及临床伦理咨询(CEC)的实施情况。最后,评估内科医生参与高等专科医院的情况。材料和方法:一项横断面描述性研究,通过一项自我管理的在线调查进行,该调查于2025年2月至5月分发给全国所有确定的hec。结果:在全国235家经认证的高等学校中,共有112家(47.66%)参与。每个委员会的平均成员人数为16人(范围:6-29人)。最具代表性的专业是护理和医学。在99.1%的委员会中,至少有一名成员接受过生物伦理学研究生培训。每年最频繁的会议范围是7至12次(46.8%)。大多数高等学校(91.1%)参与了教育活动,58%的高等学校制定了伦理文件。大多数病例每年复查1 - 5例(69.6%)。40.2%的高等教育中心确立了中央协调委员会的作用,18.8%的高等教育中心处于执行过程中。内科医生出现在54%的hec中。在65%的病例中,内科医生是CEC的一部分。结论:西班牙的高等教育机构在教育活动和道德文件的制定方面表现出了显著的参与;但是,他们每年接受的咨询次数相对较少。临床伦理咨询正逐渐纳入高等医院的架构,这可能会加强对伦理咨询的管理。内科医生是超过一半的高等医疗保健委员会的成员,在这些委员会的运作中发挥着非常积极的作用。
{"title":"Current situation and role of internists in healthcare ethics committees in Spain. PANACEAS study.","authors":"P Durán Del Campo, G Solano Iturri, B Alonso Ortiz, J Bertran Muñoz, A M Bravo Blanco, L Briongos Figuero, C Carrera García, A D Chacón Moreno, A Blanco Portillo, J M Galván-Román","doi":"10.1016/j.rceng.2026.502483","DOIUrl":"10.1016/j.rceng.2026.502483","url":null,"abstract":"<p><strong>Objectives: </strong>To analyze the current situation of Healthcare Ethics Committees (HECs) in Spain, their composition and functions, as well as the implementation of Clinical Ethics Consultancy (CEC). Finally, to assess the involvement of internists in HECs.</p><p><strong>Materials and methods: </strong>A cross-sectional descriptive study conducted through a self-administered online survey distributed between February and May 2025 to all identified HECs in the country.</p><p><strong>Results: </strong>A total of 112 HECs (47.66%) out of the 235 accredited nationwide participated. The average number of members per committee was 16 (range: 6-29). The most represented professional profiles were nursing and medicine. In 99.1% of the committees, at least one member had postgraduate training in Bioethics. The most frequent range of meetings per year was between 7 and 12 (46.8%). Most HECs (91.1%) were involved in educational activities, and 58% had produced ethical documents. The majority reviewed between 1 and 5 cases annually (69.6%). The CEC role was established in 40.2% of HECs and in the process of implementation in 18.8%. Internists were present in 54% of HECs. In 65% of cases, the internist is part of the CEC.</p><p><strong>Conclusions: </strong>HECs in Spain demonstrate significant involvement in educational activities and the development of ethical documents; however, they receive a relatively low number of annual consultations. Clinical Ethics Consultancy is gradually being integrated into the structure of HECs, which may enhance the management of ethical inquiries. Internists are members of more than half of the HECs and play a very active role in their operations.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502483"},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Procalcitonin and Midregional proadrenomedullin (MR-proADM) could help make home hospitalization of patients seen for suspected infection in the Emergency Department safer. 降钙素原和中部肾上腺髓质素原(MR-proADM)可使在急诊科就诊的疑似感染患者更安全地在家住院。
Pub Date : 2026-02-02 DOI: 10.1016/j.rceng.2026.502472
J Cabañas Morafraile, L S Martín, E de Rafael González, A Julián-Jiménez
{"title":"Procalcitonin and Midregional proadrenomedullin (MR-proADM) could help make home hospitalization of patients seen for suspected infection in the Emergency Department safer.","authors":"J Cabañas Morafraile, L S Martín, E de Rafael González, A Julián-Jiménez","doi":"10.1016/j.rceng.2026.502472","DOIUrl":"10.1016/j.rceng.2026.502472","url":null,"abstract":"","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502472"},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Heart failure with preserved ejection fraction: Updated diagnostic and therapeutic strategies. SEMI consensus document. 保留射血分数的心力衰竭:最新的诊断和治疗策略。SEMI共识文件。
Pub Date : 2026-02-02 DOI: 10.1016/j.rceng.2026.502471
J M Fernández Rodríguez, M B Alonso-Ortíz, J Casado Cerrada, D Chivite Guillen, P Cubo Romano, R García Alonso, A Lorenzo Almorós, J P Miramontes-González, L Soler Rangel, J Pérez-Silvestre

Heart failure (HF) is associated with high morbidity and mortality. HF with preserved left ventricular ejection fraction (HF-pEF) accounts for up to 50% of all HF cases, being the most common in elderly patients. In addition, these subjects frequently present other comorbidities. For all these reasons, the diagnosis of patients with HF-pEF is complex and requires a careful approach. In addition, there are "secondary" or HF-pEF forms that must also be discarded. The treatment of HF-pEF has evolved very significantly in recent years due to evidence from clinical trials. Until a few years ago, the management was based on the treatment of congestive symptoms with diuretics and comorbidities, to this was added the indication of treatment with SGLT2 inhibitors, after being shown to reduce hospitalizations due to HF, and more recently new evidence of clinical benefit with other drugs such as finerenone, semaglutide or tirzepatide has been published. All this makes it necessary to update the recommendations regarding the management of patients with HF-pEF.

心力衰竭(HF)与高发病率和死亡率相关。保留左心室射血分数(HF- pef)的HF占所有HF病例的50%,在老年患者中最常见。此外,这些受试者经常出现其他合并症。由于所有这些原因,对HF-pEF患者的诊断是复杂的,需要谨慎的方法。此外,还有“次级”或HF-pEF形式也必须丢弃。由于来自临床试验的证据,近年来HF-pEF的治疗有了非常显著的发展。直到几年前,治疗的基础是用利尿剂和合并症治疗充血性症状,在此基础上增加了SGLT2抑制剂治疗的适应症,在被证明可以减少HF的住院治疗后,最近有新的证据表明使用其他药物如芬尼酮、西马鲁肽或替西帕肽有临床益处。所有这些都使得有必要更新有关HF-pEF患者管理的建议。
{"title":"Heart failure with preserved ejection fraction: Updated diagnostic and therapeutic strategies. SEMI consensus document.","authors":"J M Fernández Rodríguez, M B Alonso-Ortíz, J Casado Cerrada, D Chivite Guillen, P Cubo Romano, R García Alonso, A Lorenzo Almorós, J P Miramontes-González, L Soler Rangel, J Pérez-Silvestre","doi":"10.1016/j.rceng.2026.502471","DOIUrl":"10.1016/j.rceng.2026.502471","url":null,"abstract":"<p><p>Heart failure (HF) is associated with high morbidity and mortality. HF with preserved left ventricular ejection fraction (HF-pEF) accounts for up to 50% of all HF cases, being the most common in elderly patients. In addition, these subjects frequently present other comorbidities. For all these reasons, the diagnosis of patients with HF-pEF is complex and requires a careful approach. In addition, there are \"secondary\" or HF-pEF forms that must also be discarded. The treatment of HF-pEF has evolved very significantly in recent years due to evidence from clinical trials. Until a few years ago, the management was based on the treatment of congestive symptoms with diuretics and comorbidities, to this was added the indication of treatment with SGLT2 inhibitors, after being shown to reduce hospitalizations due to HF, and more recently new evidence of clinical benefit with other drugs such as finerenone, semaglutide or tirzepatide has been published. All this makes it necessary to update the recommendations regarding the management of patients with HF-pEF.</p>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":" ","pages":"502471"},"PeriodicalIF":0.0,"publicationDate":"2026-02-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146121532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic value of clinical judgment versus the ELAN-HF and BCN-Bio-HF risk scores after hospitalization for acute heart failure 急性心力衰竭住院后临床判断与ELAN-HF和BCN-Bio-HF风险评分的预后价值
Pub Date : 2026-02-01 DOI: 10.1016/j.rceng.2026.502451
A. Fraile Sanz , D. Abad Pérez , M. Álvarez Bello , M. Laserna Martínez , I. Luis Saludes , J.A. Perea Egido , R. Mata Caballero , I.J. Thuissard-Vasallo , J. Casado

Introduction and objectives

Heart failure (HF) is a highly prevalent condition, particularly among the elderly, and is associated with high rates of readmission and mortality. To improve prognosis, risk assessment tools such as ELAN-HF and BCN-Bio-HF have been developed to estimate mortality after a hospitalization for HF. However, in clinical practice, risk evaluation is often based on the physician’s subjective perception. This study aims to compare that perception with the mortality predictions generated by these tools.

Methods

A retrospective, observational study was conducted in a secondary-level hospital between 2019 and 2021, including patients recently discharged after hospitalization for HF. At the first follow-up visit, physicians subjectively classified the patients’ risk into three levels without access to the results of the risk scores. Afterwards, the ELAN-HF and BCN-Bio-HF scores were calculated and compared with clinical outcomes at 12 months. The predictive capacity of each method was evaluated.

Results

A total of 125 patients were included (median age: 76 years [71,5–83], 56% male). The overall mortality rate was 34.4%. The ELAN-HF and BCN-Bio-HF scores better identified high-risk patients than the clinical assessment, which underestimated mortality in the low-risk group. ROC curve analysis showed good predictive ability for mortality, particularly for the BCN-Bio-HF score (AUC: 74.6%).

Conclusions

The results support that risk scores are more accurate than physicians’ subjective evaluation in predicting mortality in patients with HF. Their integration into clinical practice is recommended, given their prognostic value and usefulness in patient follow-up.
前言和目的:心力衰竭(HF)是一种非常普遍的疾病,特别是在老年人中,并与高再入院率和死亡率相关。为了改善预后,已经开发了ELAN-HF和BCN-Bio-HF等风险评估工具来估计HF住院后的死亡率。然而,在临床实践中,风险评估往往是基于医生的主观感知。这项研究旨在将这种看法与这些工具产生的死亡率预测进行比较。方法:2019 - 2021年在某二级医院进行回顾性观察性研究,纳入心力衰竭住院后近期出院的患者。在第一次随访时,医生在无法获得风险评分结果的情况下,主观地将患者的风险分为三个级别。随后,计算ELAN-HF和BCN-Bio-HF评分,并与12个月时的临床结果进行比较。对每种方法的预测能力进行了评价。结果:共纳入125例患者(中位年龄:76岁[71,5-83],56%为男性)。总死亡率为34.4%。与临床评估相比,ELAN-HF和BCN-Bio-HF评分能更好地识别高危患者,而临床评估低估了低危组的死亡率。ROC曲线分析显示,BCN-Bio-HF评分对死亡率具有较好的预测能力(AUC: 74.6%)。结论:结果支持风险评分比医生的主观评价更准确地预测心衰患者的死亡率。鉴于其预后价值和对患者随访的有用性,建议将其纳入临床实践。
{"title":"Prognostic value of clinical judgment versus the ELAN-HF and BCN-Bio-HF risk scores after hospitalization for acute heart failure","authors":"A. Fraile Sanz ,&nbsp;D. Abad Pérez ,&nbsp;M. Álvarez Bello ,&nbsp;M. Laserna Martínez ,&nbsp;I. Luis Saludes ,&nbsp;J.A. Perea Egido ,&nbsp;R. Mata Caballero ,&nbsp;I.J. Thuissard-Vasallo ,&nbsp;J. Casado","doi":"10.1016/j.rceng.2026.502451","DOIUrl":"10.1016/j.rceng.2026.502451","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Heart failure (HF) is a highly prevalent condition, particularly among the elderly, and is associated with high rates of readmission and mortality. To improve prognosis, risk assessment tools such as ELAN-HF and BCN-Bio-HF have been developed to estimate mortality after a hospitalization for HF. However, in clinical practice, risk evaluation is often based on the physician’s subjective perception. This study aims to compare that perception with the mortality predictions generated by these tools.</div></div><div><h3>Methods</h3><div>A retrospective, observational study was conducted in a secondary-level hospital between 2019 and 2021, including patients recently discharged after hospitalization for HF. At the first follow-up visit, physicians subjectively classified the patients’ risk into three levels without access to the results of the risk scores. Afterwards, the ELAN-HF and BCN-Bio-HF scores were calculated and compared with clinical outcomes at 12 months. The predictive capacity of each method was evaluated.</div></div><div><h3>Results</h3><div>A total of 125 patients were included (median age: 76 years [71,5–83], 56% male). The overall mortality rate was 34.4%. The ELAN-HF and BCN-Bio-HF scores better identified high-risk patients than the clinical assessment, which underestimated mortality in the low-risk group. ROC curve analysis showed good predictive ability for mortality, particularly for the BCN-Bio-HF score (AUC: 74.6%).</div></div><div><h3>Conclusions</h3><div>The results support that risk scores are more accurate than physicians’ subjective evaluation in predicting mortality in patients with HF. Their integration into clinical practice is recommended, given their prognostic value and usefulness in patient follow-up.</div></div>","PeriodicalId":94354,"journal":{"name":"Revista clinica espanola","volume":"226 2","pages":"Article 502451"},"PeriodicalIF":0.0,"publicationDate":"2026-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145954668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Revista clinica espanola
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1